doi: 10.1056/NEJM199107183250310.
Drug promotion and scientific exchange. The role of the clinical investigator
Affiliations
- PMID: 2052064
- DOI: 10.1056/NEJM199107183250310
Item in Clipboard
Drug promotion and scientific exchange. The role of the clinical investigator
N Engl J Med.
.
No abstract available
Comment in
-
Drug promotion and scientific exchange.N Engl J Med. 1992 Jan 9;326(2):133-4. doi: 10.1056/NEJM199201093260210. N Engl J Med. 1992. PMID: 1550609 No abstract available.
-
Drug promotion and scientific exchange.N Engl J Med. 1992 Jan 9;326(2):133; author reply 134. N Engl J Med. 1992. PMID: 1727221 No abstract available.
-
Drug promotion and scientific exchange.N Engl J Med. 1992 Jan 9;326(2):133; author reply 134. N Engl J Med. 1992. PMID: 1727222 No abstract available.
-
Drug promotion and scientific exchange.N Engl J Med. 1992 Jan 9;326(2):134. N Engl J Med. 1992. PMID: 1727223 No abstract available.
-
Drug promotion and scientific exchange.N Engl J Med. 1992 Jan 9;326(2):134. N Engl J Med. 1992. PMID: 1727224 No abstract available.
Similar articles
-
FDA enlists doctors to help spot misleading drug advertisements.BMJ. 2010 May 14;340:c2594. doi: 10.1136/bmj.c2594. BMJ. 2010. PMID: 20472679 No abstract available.
-
Truth in advertising: FDA approval and the physician's responsibility.Anesthesiology. 1992 Mar;76(3):477-8. Anesthesiology. 1992. PMID: 1539866 No abstract available.
-
Program seeks to enlist physicians to flag questionable promotion of drugs.JAMA. 2010 Jul 7;304(1):28-9. doi: 10.1001/jama.2010.861. JAMA. 2010. PMID: 20606140 No abstract available.
-
Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.J Clin Pharmacol. 2010 Jul;50(7):842-7. doi: 10.1177/0091270009356572. Epub 2010 Feb 12. J Clin Pharmacol. 2010. PMID: 20154293 Review. No abstract available.
-
Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.J Contemp Health Law Policy. 2003 Spring;19(2):495-520. J Contemp Health Law Policy. 2003. PMID: 14748255 Review. No abstract available.
Cited by
-
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view.J Gen Intern Med. 1996 Oct;11(10):642-4. doi: 10.1007/BF02599035. J Gen Intern Med. 1996. PMID: 8945699 No abstract available.
-
When science and passion meet: the impact of AIDS on research.CMAJ. 1993 Feb 15;148(4):638-42. CMAJ. 1993. PMID: 8431829 Free PMC article. No abstract available.
-
Drug company marketing in the groves of academe.West J Med. 1992 Jun;156(6):660-1. West J Med. 1992. PMID: 1615668 Free PMC article. No abstract available.
-
Developing new drugs for cancer.BMJ. 1991 Oct 26;303(6809):1005-6. doi: 10.1136/bmj.303.6809.1005. BMJ. 1991. PMID: 1805823 Free PMC article. No abstract available.
-
Acceptance of external funds by physician organizations: issues and policy options.J Gen Intern Med. 1995 Nov;10(11):624-30. doi: 10.1007/BF02602746. J Gen Intern Med. 1995. PMID: 8583265 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
